MONICA
CABRERO CALVO
Investigadora Predoctoral
Publicaciones (37) Publicaciones de MONICA CABRERO CALVO
2024
2022
-
ABCL-297 Hemophagocytic Lymphohistiocytosis Singularity: A Multicenter Retrospective Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S369-S370
-
Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups
Cancers, Vol. 14, Núm. 22
-
CT-169 Cytokine Release Syndrome After Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide: Time of Onset Matters
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S437-S438
-
CT-275 Incidence and Characteristics of Chronic GVHD in Haploidentical Stem-Cell Transplantation With Post-Transplantation Cyclophosfamide: Experience of the Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH-TC)
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S440-S441
-
MM-198 Anti-BCMA Therapy in Multiple Myeloma: A Single-Center Experience
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S413
2021
-
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
Bone Marrow Transplantation, Vol. 56, Núm. 8, pp. 1919-1928
-
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 10, pp. e801-e809
-
Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors
Bone Marrow Transplantation
2020
-
Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic
Frontiers in Medicine, Vol. 7
2019
-
Anemia hemolítica
Manual terapéutico (Ediciones Universidad de Salamanca), pp. 389-393
-
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation
Annals of Hematology, Vol. 98, Núm. 9, pp. 2151-2162
-
Drug-induced thrombotic microangiopathy during maintenance treatment in a patient with multiple myeloma
HemaSphere, Vol. 3, Núm. 3
-
Púrpura trombótica trombocitopénica (PTT) / síndrome hemolítico urémico atípico (SHUA)
Manual terapéutico (Ediciones Universidad de Salamanca), pp. 394-396
-
Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation
Bone Marrow Transplantation
2017
-
18F-FDG PET/CT in the clinical management of patients with lymphoma
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 36, Núm. 5, pp. 312-321
-
Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents
American Journal of Hematology, Vol. 92, Núm. 4, pp. 351-358
-
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Biology of Blood and Marrow Transplantation, Vol. 23, Núm. 1, pp. 53-59
2016
-
Down-regulation of EZH2 expression in myelodysplastic syndromes
Leukemia Research, Vol. 44, pp. 1-7
-
Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletion
British Journal of Haematology